For nonmalignant gynecological diseases, high DHEAS levels reduced the risk of endometriosis (OR = 0.840, P = 0.016) and increased the risk of PCOS (OR= 1.970, P = 0.014). This evidence concerns the gene SULT2A1 and female reproductive system disorder.